Search

Harnal D

Harnal D

tamsulosin

Manufacturer:

Astellas

Distributor:

Firma Chun Cheong
/
DKSH
Concise Prescribing Info
Contents
Tamsulosin HCl
Indications/Uses
Symptomatic treatment of bladder outlet obstruction associated w/ benign prostatic hyperplasia.
Click to view Harnal D detailed prescribing information
Dosage/Direction for Use
0.2 mg once daily.
Click to view Harnal D detailed prescribing information
Administration
Should be taken with food: Place on the tongue & allow to dissolve then, swallow w/ or w/o water.
Contraindications
Hypersensitivity.
Click to view Harnal D detailed prescribing information
Special Precautions
Observe patients for any changes in BP occurring w/ postural change. Confirm use of any antihypertensive agents prior to treatment initiation. Closely monitor BP during concurrent treatment w/ antihypertensives. Reports of intraoperative floppy iris syndrome in patients currently taking or w/ history of treatment w/ α1-blockers. Patients w/ orthostatic hypotension. Patients w/ past history of sulfonamide hypersensitivity. May impair ability to drive or operate machinery. Patients w/ severe renal or hepatic impairment. Elderly.
Click to view Harnal D detailed prescribing information
Adverse Reactions
Dizziness, swaying feeling; tachycardia; rash; stomach discomfort, queasy, vomiting, stomach heaviness, gastralgia, anorexia, dysphagia; burning sensation of pharynx, general malaise.
Click to view Harnal D detailed prescribing information
Drug Interactions
Orthostatic hypotension w/ antihypertensives. Enhanced vasodilatory hypotensive action of phosphodiesterase-5 inhibitors eg, sildenafil citrate, vardenafil HCl hydrate. Significant increase in exposure when co-administered w/ a strong CYP3A4 inhibitor eg, ketoconazole, itraconazole, ritonavir, atazanavir sulfate, indinavir sulfate, nelfinavir, saquinavir mesylate, clarithromycin, telithromycin. Do not use in combination w/ strong CYP3A4 inhibitors in patients known to be CYP2D6 poor metabolizers.
Click to view Harnal D detailed prescribing information
Caution For Usage
For caution against possible variation of physical aspect of medicine... Click to view Harnal D detailed prescribing information
Storage
View Harnal D storage conditions for details to ensure optimal shelf-life.
Description
View Harnal D description for details of the chemical structure and excipients (inactive components).
Action
View Harnal D mechanism of action for pharmacodynamics and pharmacokinetics details.
MIMS Class
Drugs for Bladder & Prostate Disorders
ATC Classification
G04CA02 - tamsulosin ; Belongs to the class of alpha-adrenoreceptor antagonists. Used in the treatment of benign prostatic hypertrophy.
Presentation/Packing
Form
Harnal D XR tab 0.2 mg
Packing/Price
28's
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Already a member? Sign in
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Already a member? Sign in